TY  - GEN
AU  - Lichtenstein,Kenneth A
AU  - Armon,Carl
AU  - Nagabhushanam,Vijaya
AU  - Efaw,Benjamin J
AU  - Frazer-Abel,Ashley
AU  - Hiserote,Melissa E
AU  - Alam,Rafeul
TI  - A pilot study to assess inflammatory biomarker changes when raltegravir is added to a virologically suppressive HAART regimen in HIV-1-infected patients with limited immunological responses
SN  - 2040-2058
PY  - 2013///0426
KW  - Adult
KW  - Aged
KW  - Antiretroviral Therapy, Highly Active
KW  - methods
KW  - Biomarkers
KW  - metabolism
KW  - CD4-CD8 Ratio
KW  - CD4-Positive T-Lymphocytes
KW  - immunology
KW  - CD8-Positive T-Lymphocytes
KW  - Chemokine CCL5
KW  - Disease Progression
KW  - Female
KW  - HIV Infections
KW  - drug therapy
KW  - HIV-1
KW  - pathogenicity
KW  - Humans
KW  - Immunologic Memory
KW  - Inflammation
KW  - Inflammation Mediators
KW  - Lymphocyte Activation
KW  - Male
KW  - Middle Aged
KW  - Pilot Projects
KW  - Pyrrolidinones
KW  - pharmacology
KW  - Raltegravir Potassium
KW  - Viral Load
KW  - gag Gene Products, Human Immunodeficiency Virus
KW  - nef Gene Products, Human Immunodeficiency Virus
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.3851/IMP2350
ER  -